← back to database
Nimbus Synergies leads early-stage investments in health technology companies transforming care across Canada, from pre-seed through Series A. They target companies with $500K-$2M ARR and $5M-$20M pre-money valuations, writing first checks of $250K-$2M for 10-20% ownership, and do not invest in therapeutics or Class III medical devices.
Primary stage
Lead / follow
Initial check size
Investment focus
Investment style
Specialist
Data last enriched
Aug 14, 2026
Investing team
- Jason RobertsonCEO
- Laura CassinPrincipal
- Nidhi Kamal MohanInvestment Associate